Hsa-miR-223-3p participates in the process of anthracycline-induced cardiomyocyte damage by regulating NFIA gene
暂无分享,去创建一个
[1] C. Tiribelli,et al. The role of microRNA in the resistance to treatment of hepatocellular carcinoma. , 2019, Annals of translational medicine.
[2] Wei Zhu,et al. MiR-212-3p inhibits cell proliferation and promotes apoptosis by targeting nuclear factor IA in bladder cancer , 2019, Journal of Biosciences.
[3] J. Blanco,et al. Insights into the transcriptional regulation of the anthracycline reductase AKR7A2 in human cardiomyocytes. , 2019, Toxicology letters.
[4] Ming-yue Li,et al. Absence of miR‐223‐3p ameliorates hypoxia‐induced injury through repressing cardiomyocyte apoptosis and oxidative stress by targeting KLF15 , 2018, European journal of pharmacology.
[5] L. Skálová,et al. MicroRNAs in the diagnosis and prevention of drug-induced cardiotoxicity , 2018, Archives of Toxicology.
[6] Peng Li,et al. Prognostic significance of NFIA and NFIB in esophageal squamous carcinoma and esophagogastric junction adenocarcinoma , 2018, Cancer medicine.
[7] W. Maloney,et al. miR-223-3p Inhibits Human Osteosarcoma Metastasis and Progression by Directly Targeting CDH6 , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.
[8] Bo-yu Xue,et al. miRNA-223-3p regulates NLRP3 to promote apoptosis and inhibit proliferation of hep3B cells , 2017, Experimental and therapeutic medicine.
[9] C. Shih,et al. The microRNA-302b-inhibited insulin-like growth factor-binding protein 2 signaling pathway induces glioma cell apoptosis by targeting nuclear factor IA , 2017, PloS one.
[10] D. Yellon,et al. Anthracycline Chemotherapy and Cardiotoxicity , 2017, Cardiovascular Drugs and Therapy.
[11] E. Hoxha,et al. A novel NFIA-NF&kgr;B feed-forward loop contributes to glioblastoma cell survival , 2016, Neuro-oncology.
[12] C. Larsson,et al. miR-223-3p regulates cell growth and apoptosis via FBXW7 suggesting an oncogenic role in human testicular germ cell tumors , 2016, International journal of oncology.
[13] Miki Ohira,et al. Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes , 2016, Journal of Human Genetics.
[14] Chaoqian Xu,et al. MiR-223-3p as a Novel MicroRNA Regulator of Expression of Voltage-Gated K+ Channel Kv4.2 in Acute Myocardial Infarction , 2016, Cellular Physiology and Biochemistry.
[15] E. Saleh,et al. Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy , 2015, Cancer biology & therapy.
[16] P. Duan,et al. miR-29a activates Hes1 by targeting Nfia in esophageal carcinoma cell line TE-1 , 2014, Oncology letters.
[17] Stephen T. C. Wong,et al. The miR-223/Nuclear Factor I-A Axis Regulates Glial Precursor Proliferation and Tumorigenesis in the CNS , 2013, The Journal of Neuroscience.
[18] H. Hermeking,et al. MicroRNA-34a regulates cardiac ageing and function , 2013, Nature.
[19] K. Chowdhury,et al. The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy , 2012, Nature Communications.
[20] O. Kent,et al. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes , 2006, Oncogene.
[21] L. Gianni,et al. Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity , 2004, Pharmacological Reviews.
[22] V. Ambros,et al. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.
[23] R. J. Cersosimo,et al. Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.